It has been proposed that the steroidogenic acute regulatory (StAR) protein is the protein responsible for the acute regulation of steroid hormone biosynthesis. Virtually all of the observations made to date are consistent with this proposal. In this short review, background information leading to the discovery and characterization of the StAR protein and several recent and interesting observations concerning this protein are summarized.
Steroid hormones play extremely important roles in maintaining bodily homeostasis and reproductive capacity. For example, the adrenal mineralocorticoid aldosterone is essential for maintaining salt balance and, hence, blood pressure, while adrenal glucocorticoids serve to regulate carbohydrate metabolism and also to formulate reactions to stress and other bodily insults. In females, the ovarian and placental steroids, namely oestrogen and progesterone, are requirements for follicular development, ovulation, development and maintenance of secondary sex characteristics and also for sustaining pregnancy should it occur. The most prevalent male hormone, testosterone, and its biologically active androgenic counterpart, dihydrotestosterone, are essential for normal spermatogenesis and for development and maintenance of the secondary sex characteristics in males. Therefore, the steroid hormones play important roles in many species, and maintaining normal concentrations of steroids in the body through their regulated synthesis is important. An equally important consideration is the means by which the synthesis of the steroid hormones are regulated by events occurring in the hypothalamic-pituitary-adrenal/gonadal axis through the actions of trophic hormone releasing hormones and trophic hormones themselves. Briefly, adrenocorticotrophic hormone (ACTH), LH or FSH will be released from specialized cells in the anterior pituitary through the action of corticotrophin-releasing hormone (CRH) or GnRH. After this release, the trophic hormones will interact with specific receptors on the surface of adrenal or gonadal cells and, through the intermediacy of the cAMP or the Ca 2+ second messenger system, this will result in the synthesis of the appropriate steroid hormone depending on the tissue and cell type stimulated. This review discusses the events that regulate the acute synthesis of steroid hormones in response to trophic hormone stimulation, demonstrates the role of the steroidogenic acute regulatory (StAR) protein in this process and presents several recent findings pertaining to this protein.
Acute regulation of steroid hormone biosynthesis
While much of the early work on the steroidogenic pathway indicated that the acute rate limiting step in this process was the hormone-induced increase in the activity of the cytochrome P450 side chain cleavage enzyme (P450scc), located in the inner mitochondrial membrane and functioning to convert cholesterol to pregnenolone, this proved not to be the case. Since those early observations, many studies have indicated that the true rate limiting step effected by hormone stimulation is the delivery of the substrate for all steroid hormones, cholesterol, from the outer to the inner mitochondrial membrane and the P450scc enzyme (Karaboyas et al., 1965; Simpson et al., 1979; Crivello and Jefcoate, 1980; Privalle et al., 1983; Jefcoate et al., 1987) . Diffusion of the hydrophobic cholesterol through the aqueous intermembrane space is extremely slow (Rennert et al., 1993) and, therefore, it became clear that the transfer of cholesterol from the outer membrane to the P450scc occurs in an assisted manner and that this is the rate limiting step. In simple terms, the overall production of steroids is controlled by factors that facilitate the transport of cholesterol from the mitochondrial outer membrane across the aqueous intermembrane space to the inner membrane. Several investigators observed that this regulated step was extremely sensitive to inhibitors of protein synthesis and, thus, the search for the putative regulatory protein was launched (Ferguson, 1963; Garren et al., 1965) . Several protein candidates have been proposed as the acute regulator of steroid hormone biosynthesis (for review see Stocco and Clark, 1996) . One of these proteins, the StAR protein, appears to be the only protein that possesses all of the characteristics of the putative regulator.
Steroidogenic acute regulatory (StAR) protein
The StAR protein consists of a family of 37 kDa (precursor) and 30 kDa (mature) mitochondrial proteins first observed in ACTH-stimulated adrenocortical cells (Krueger and OrmeJohnson, 1983 ). Since then, many positive correlations between the appearance of this protein and steroidogenesis have been made. However, in spite of these correlations, a direct cause and effect relationship between their expression and steroidogenesis was lacking, and it became necessary to clone the 37 kDa protein to prove its function in steroidogenesis unequivocally. A full length 1456 bp cDNA clone encoding a protein of 284 amino acids was obtained from MA-10 mouse Leydig tumour cells (Clark et al., 1994) . Transient transfection of MA-10 cells with this cDNA demonstrated that expression of the protein resulted in a significant increase in steroid production in the absence of hormone stimulation. In addition, transfection of COS-1 cells with a plasmid containing the cDNA encoding the 37 kDa protein resulted in a several-fold increase in the conversion of cholesterol to pregnenolone Sugawara et al., 1995; Stocco and Clark, 1996) . These results indicated a direct role for the 37 kDa protein in hormone-regulated steroid production and lead to the naming of the protein as StAR (steroidogenic acute regulatory protein). The importance of StAR in the regulation of steroidogenesis has also been demonstrated in studies on the disease congenital lipoid adrenal hyperplasia (lipoid CAH). Lipoid CAH is a lethal condition that results from an almost complete inability of the newborn infant to synthesize steroids. Since the block in lipoid CAH was at the locus of cholesterol delivery to the P450scc, it seemed possible that it was due to a defect in StAR expression or function. Indeed, when cDNA encoding StAR was prepared from testicular tissue of patients with lipoid CAH, identified nonsense mutations in the sequence. To date, mutations in the StAR gene are the only reported causes of this potentially lethal disease, and have clearly demonstrated the indispensable role of StAR in the production of steroids.
Recent advances in StAR research
Several recent areas of study have produced interesting and important observations concerning StAR.
Mechanism of action
It was proposed that, in response to hormone stimulation, the StAR 37 kDa precursor protein was rapidly synthesized and was targeted to, imported into and processed by the mitochondria via its N-terminal signal sequence with the concomitant formation of contact sites between the inner and outer membranes (Stocco and Clark, 1996) . This model further proposed that the formation of contact sites allowed cholesterol to be transferred from the outer to the inner mitochondrial membrane and, thus, for it to be available to the P450scc for pregnenolone synthesis. After processing, the membranes separated and no further cholesterol transfer could occur without additional synthesis and processing of StAR precursor proteins. However, a report by Arakane et al. (1996) indicated that a revision of this model was required. It has been shown that Nterminal truncations of the StAR protein which remove as many as 62 amino acids have no inhibitory effect on steroid production in COS-1 cells transfected with the cDNAs containing the truncations. Western analysis and immunostaining for StAR protein indicated that only a small amount of the truncated StAR protein was imported into the mitochondria. Therefore, it appears that import of the StAR protein is not required for maximal cholesterol transfer to the inner mitochondrial membrane. However, truncation of the C-terminus by ten amino acids resulted in a decrease in steroid production of 50%, while a 28 amino acid truncation resulted in a complete loss of steroid production (Arakane et al., 1996) . Thus, it appears that the C-terminal region of the StAR protein is extremely important in cholesterol transfer. A further indication of the importance of the C-terminal region of the StAR protein in cholesterol transfer was the demonstration by of steroid stimulating properties of a protein known as MLN64, which has significant homology to the C-terminal region of StAR. This protein was originally described as a gene product of unknown function that was highly expressed in specific breast tumours . Proteins with similarities to the C-terminal region of StAR and MLN64 have also been found in Caenorhabditis elegans, and were proposed to be as much as 600 million years old . Perhaps these proteins represent cellular proteins whose function it was to aid in the trafficking of sterols within the cell. A comparison of the sequence homology between StAR, MNL64 and the C. elegans proteins is given (Fig. 1) . Thus, regions in the C-terminal portion of the StAR protein appear to be of great importance in implementing the transfer of cholesterol to the inner mitochondrial membrane. Although the mechanism of action of the StAR protein is still unknown, it is becoming increasingly clear that cholesterol transfer requires that it interact with as yet unknown proteins or other factors on the outside of the outer mitochondrial membrane and produce alterations that result in cholesterol transfer. Therefore, much remains to be determined concerning the mechanism whereby StAR can effect cholesterol transfer to the inner mitochondrial membrane. In this regard, the identification of the components with which StAR interacts on the outer mitochondrial membrane becomes of critical importance in understanding its mechanism of action.
StAR and phosphorylation
The major signalling pathway in trophic hormone-stimulated steroidogenesis involves the activation of protein kinase A (PKA) by increased cAMP accumulation. Computer analysis and comparison of the StAR protein sequence from several species has identified two putative PKA/Cam kinase II phosphorylation sites and one PKC phosphorylation site. In an attempt to determine the role of phosphorylation on the steroidogenic capacity of the StAR protein, studies were undertaken to mutate the consensus PKA sites that appear at positions 56/57 and 194/195 in the mouse and human StAR proteins, respectively . Both sites are serines and both were altered by site-directed mutagenesis to produce alanine residues at those sites. Mutation of either site resulted in a decrease in 32 P incorporation into the StAR protein, indicating that these sites were phosphorylated in vivo. More importantly, transfection of COS-1 cells with the StAR protein containing the serine 56/57 to alanine mutation had no effect on steroidogenesis. Conversely, transfection with the serine 194/195 to alanine mutation resulted in a 50-60% inhibition of steroid biosynthesis. These results indicate that phosphorylation of the StAR protein at position 194/195 can significantly increase its biological activity, but is not required for full activity.
The StAR knockout mouse
Since it is not possible to perform many desirable studies on StAR knockouts in humans (lipoid CAH), an obvious strategy was to produce a knockout of the StAR gene in an animal system with the goal of having a model to study this protein. Caron et al. (1997) used targeted disruption of the StAR gene to produce StAR knockout mice successfully. Observations of these mice indicated that, regardless of genotype, all animals have female external genitalia and, after birth, all animals failed to grow normally and died within a short time, presumably as a result of adrenocortical insufficiency. Serum concentrations of corticosterone and aldosterone were depressed while concentrations of ACTH and CRH were increased, indicating an impairment of the production of adrenal steroids with an accompanying loss of feedback regulation at the hypothalamus or pituitary. Inspection of the adrenal gland revealed a normal medulla but an abnormal cortex, with a disrupted fascicular zone. Specific staining procedures revealed increased lipid deposits in the adrenal cortex region of the StAR knockout mouse. While the StAR knockout mice were all phenotypically sex reversed, the testes of these animals appeared normal upon gross inspection, but specific staining indicated the presence of increased concentrations of lipid within this organ. In contrast, the ovaries of the StAR knockout mice were indistinguishable from wild type animals; a similar situation was then found with human StAR mutations (Bose et al., 1997; Fujieda et al., 1997) . The availability of the StAR knockout mouse should 
Negative regulation of the StAR gene by DAX-1
While many examples of positive regulation of the StAR gene have been made, observations suggest that the StAR gene undergoes negative regulation as well. The transcription factor, DAX-1 (for dosage sensitive sex reversal; adrenal hypoplasia congenita; X chromosome; gene 1), is an unusual member of the nuclear hormone receptor family. Mutations in the human DAX-1 gene are responsible for the related diseases of adrenal hypoplasia congenita (AHC) and hypogonadotrophic hypogonadism (HHG) Zanaria et al., 1994) . In addition, duplication of the X chromosome in the Xp21 region, which houses the DAX-1 gene, results in male to female sex reversal, a condition known as dosage sensitive sex reversal (DSS) . The DAX-1 protein only retains homology with the ligand binding domain of the nuclear hormone receptors. The DNA binding domain lacks canonical zinc finger motifs and consists of 3.5 repeats of a 65-67 amino acid sequence in its N-terminus . DAX-1 expression has been shown to inhibit the synthesis of steroids in Y-1 mouse adrenal tumour cells, and this block can be attributed to an inhibition of the expression of the StAR gene that occurs when excess DAX-1 is present . DAX-1 was shown to inhibit StAR gene expression by binding to a hairpin structure in a region of single stranded DNA found in the promotor region of the StAR gene . Indeed, the DAX-1 protein has been demonstrated to contain a powerful transcriptional silencing domain in its Cterminal region . Thus, it is possible that the observed phenotype in DSS is the result of the excess DAX-1 that arises from the duplication of the Xp21 region of the X chromosome. If this is the case, it represents a situation in which the negative regulation of the StAR gene has serious consequences, a situation analogous to the synthesis of nonfunctional StAR protein in lipoid CAH.
